GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Vaccine Inc (SZSE:301207) » Definitions » ROE % Adjusted to Book Value

Hualan Biological Vaccine (SZSE:301207) ROE % Adjusted to Book Value : 5.64% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Hualan Biological Vaccine ROE % Adjusted to Book Value?

Hualan Biological Vaccine's ROE % for the quarter that ended in Dec. 2023 was 14.99%. Hualan Biological Vaccine's PB Ratio for the quarter that ended in Dec. 2023 was 2.66. Hualan Biological Vaccine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 5.64%.


Hualan Biological Vaccine ROE % Adjusted to Book Value Historical Data

The historical data trend for Hualan Biological Vaccine's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Vaccine ROE % Adjusted to Book Value Chart

Hualan Biological Vaccine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - - 3.86 5.50

Hualan Biological Vaccine Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 1.99 0.28 10.71 5.64

Competitive Comparison of Hualan Biological Vaccine's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Hualan Biological Vaccine's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hualan Biological Vaccine's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Vaccine's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Hualan Biological Vaccine's ROE % Adjusted to Book Value falls into.



Hualan Biological Vaccine ROE % Adjusted to Book Value Calculation

Hualan Biological Vaccine's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=14.63% / 2.66
=5.50%

Hualan Biological Vaccine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=14.99% / 2.66
=5.64%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hualan Biological Vaccine ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Hualan Biological Vaccine's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Vaccine (SZSE:301207) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Website
Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.

Hualan Biological Vaccine (SZSE:301207) Headlines

No Headlines